Gotham Asset Management’s Amicus Therapeutics FOLD Stock Holding History

Gotham Asset Management’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.02M	Sell	139,526 -25	-0%	-$358	0.01%	1108
2025 Q4	$1.99M	Buy	139,551 +1,028	+0.7%	+$10.1K	0.01%	1044
2025 Q3	$1.09M	Buy	138,523 +1,987	+1%	+$14.1K	﹤0.01%	1173
2025 Q2	$782K	Buy	136,536 +82,546	+153%	+$533K	﹤0.01%	1204
2025 Q1	$441K	Buy	+53,990	New	+$500K	﹤0.01%	1272
2023 Q4	–	Sell	-10,606	Closed	-$129K	–	1368
2023 Q3	$129K	Sell	10,606 -5,652	-35%	-$72.9K	﹤0.01%	1275
2023 Q2	$204K	Sell	16,258 -20,242	-55%	-$240K	﹤0.01%	1230
2023 Q1	$405K	Buy	36,500 +18,466	+102%	+$228K	0.01%	1033
2022 Q4	$220K	Buy	+18,034	New	+$203K	0.01%	1111
2022 Q3	–	Sell	-11,561	Closed	-$124K	–	1201
2022 Q2	$124K	Buy	+11,561	New	+$95.2K	﹤0.01%	1070
2022 Q1	–	Sell	-26,356	Closed	-$304K	–	1167
2021 Q4	$304K	Buy	26,356 +9,537	+57%	+$106K	0.01%	942
2021 Q3	$161K	Buy	+16,819	New	+$172K	0.01%	986
2019 Q2	–	Sell	-11,047	Closed	-$150K	–	1188
2019 Q1	$150K	Buy	+11,047	New	+$135K	﹤0.01%	1125
2017 Q3	–	Sell	-30,628	Closed	-$308K	–	953
2017 Q2	$308K	Buy	+30,628	New	+$246K	﹤0.01%	825

Other funds holding FOLD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Gotham Asset Management's FOLD Position: Q1 2026 in Review

Gotham Asset Management reduced its Amicus Therapeutics (FOLD) stake by 0.02% in Q1 2026, selling an estimated $358 and leaving 139,526 shares worth $2.02M. The position accounts for 0.01% of the portfolio, ranked #1108.

Gotham Asset Management first reported a position in FOLD in Q2 2017 and has held it in 14 quarters since. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

Gotham Asset Management held 139,526 shares of Amicus Therapeutics worth $2.02M as of Q1 2026.
Gotham Asset Management sold 25 Amicus Therapeutics shares in Q1 2026, an estimated $358.
Amicus Therapeutics made up 0.01% of Gotham Asset Management's portfolio in Q1 2026, its #1108 holding.
Gotham Asset Management first reported a position in Amicus Therapeutics in Q2 2017 and has held it in 14 quarters since.
298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Gotham Asset Management's 13F filing for Q1 2026, filed 15 May 2026.